The Jordan Company (Resolute V) Invests in WEP Group Holdings (WEP Clinical)
November 18, 2021
Affiliates of The Resolute Fund V, managed by The Jordan Company, completed an investment in WEP Group Holdings Limited (WEP Clinical), with co-founders Jaswinder and Jaswant Khera remaining significant owners. The capital will support WEP Clinical's organic and inorganic growth as it expands its expanded-access, distribution, pharmacovigilance and market-access services for drug developers worldwide.
- Buyers
- The Jordan Company, L.P. (via affiliates of The Resolute Fund V, L.P.)
- Targets
- WEP Group Holdings Limited (WEP Clinical)
- Industry
- Healthcare Services
- Location
- United Kingdom
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
WEP Clinical Acquires Netherlands-Based CRO Siron Clinical
January 14, 2026
Healthcare Services
WEP Clinical, a global contract research organization, has acquired Netherlands-based Siron Clinical to expand its European footprint and enhance Phase I–IV trial delivery capabilities. Siron — with offices in Belgium and Germany and a track record in orphan, pediatric, and medical device trials — will be integrated into WEP’s Clinical Trials division to broaden operational capacity and geographic reach.
-
Ares Management Invests $375M in WHP Global
March 8, 2023
Consumer Products
Funds managed by Ares Management's Private Equity Group invested $375 million in WHP Global at a $1.6 billion valuation to provide growth capital for the company's next phase of brand acquisitions. As part of the transaction, Ares partners Jordan Smith and Aaron Rosen will join WHP Global's board to support the company's M&A-driven expansion.
-
Leonard Green & Partners Leads Recapitalization of WCG with Arsenal and Novo Holdings
November 14, 2019
Healthcare Services
An investor group led by Leonard Green & Partners, in partnership with Arsenal Capital Partners and Novo Holdings A/S, has agreed to recapitalize WCG to provide resources to accelerate growth and expand capabilities in clinical trial optimization. Financial terms were not disclosed; the transaction was announced in November 2019 and expected to close in the first quarter of 2020.
-
Curewell Capital Majority Investment in Wilmington PharmaTech
October 21, 2025
Pharmaceuticals
Los Angeles-based private equity firm Curewell Capital has made a majority investment in Wilmington PharmaTech (WPT), a U.S.-based specialty CRDMO focused on small-molecule API development and manufacturing. Founder and CEO Hui-Yin "Harry" Li will retain a significant ownership stake and remain as CEO; the capital will be used to expand WPT's U.S. manufacturing capacity, including HPAPI suites, and scale end-to-end API development and manufacturing capabilities.
-
Kelso & Company and Blue Wolf Capital Partners Acquire Jordan Health Services from Palladium Equity Partners
May 15, 2018
Healthcare Services
Affiliates of Palladium Equity Partners completed the sale of the parent of Jordan Health Services to Kelso & Company and Blue Wolf Capital Partners. The buyers combined Jordan with Great Lakes Caring and National Home Health Care to create a large national home-based care platform serving tens of thousands of patients and employing thousands of caregivers across multiple states.
-
Whistler Capital Partners Makes Strategic Growth Investment in Heart + Paw
January 3, 2024
Healthcare Services
Whistler Capital Partners, a Nashville-based healthcare-focused private equity firm, has made a significant strategic growth investment in Heart + Paw, a multi-service veterinary and pet care platform. The capital will support Heart + Paw’s de novo expansion, technology and operations investments, and its veterinarian joint-venture model; financial terms were not disclosed.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.